INCR
NASD InterCure Ltd.$5.42 ↑ +0.00 (+0.00%) Trading Up from the previous close of $5.42, and at the day’s high of $5.42
- YTD change
- +495.60%
- vs 20-day SMA
- +2.64%
- vs 200-day SMA
- +250.45%
Price ranges
Price & Performance
+4.67 (+622.67%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 38.2% away from all-time highs of $8.77
- INCR is up 496% since the beginning of the year
- INCR is up 237% over the past 12 months
- INCR is up 0% over the past 1 month
- 0% of all INCR investors are betting against INCR
INCR reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +234.6%.
- Previous minute
- +$0.00
- Last hour
- +$0.10
- Last 5 days
- +3.04%
- vs 8-day SMA
- +2.53%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.